New eye implant could reduce glaucoma drops
NCT ID NCT05236439
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a small implant called Supraflow v2.2 in 57 adults with open-angle or narrow-angle glaucoma. The implant is placed inside the eye to help drain fluid and lower eye pressure. The goal was to see if it safely reduces pressure and the need for daily eye drops over 24 months.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLAUCOMA, NARROW ANGLE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Malayan center
Yerevan, Yerevan, Armenia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Micro-Coil stent aims to drain glaucoma pressure during cataract surgery
- Eye implant could replace daily drops for glaucoma
- Eye strain test may forecast glaucoma course
- Eye drop combo study for glaucoma halted early
- Could a zapping headband save your sight?
- New stitch technique aims to prevent dangerous low eye pressure after glaucoma surgery